Companies / GSK

GSK

Company
Related drugs
9
Related conditions
16

Recent developments

AstraZeneca Deepens China Push With COPD Drug License, Lung Cancer Deal and $15bn Investment pharma.economictimes.indiatimes.com ↗
Patent Cliff: Blockbuster Drugs Worth Up to $500B Face Generic Competition pharmaceuticalcommerce.com ↗
US Tariff Plan Spurs Massive Pharma Investment Wave, Indian Generics on Notice pharma.economictimes.indiatimes.com ↗
Anti-Kickback Penalties Only 2.2% of Drug Revenue, Study Finds; Pfizer Discloses Q2 2026 Lobbying politico.com ↗
Sanofi Announces Leadership Transition and Key Regulatory Updates Amid Pipeline Advancements theglobeandmail.com ↗
Onco-Innovations Advances ONC010 Manufacturing to Kilogram Scale, Signs AI Partnerships With AstraZeneca and GSK biospace.com ↗
GSK's Bepirovirsen Achieves 19% Functional Cure Rate in Phase III Hepatitis B Trials drugs.com ↗
Trump Imposes 100% Tariffs on Drugmakers Without Price Deals swissinfo.ch ↗
CAMP4 Therapeutics Appoints Michael MacLean to Board, Advances SYNGAP1 Program theglobeandmail.com ↗
GSK's Risvutatug Rezetecan Receives Orphan Drug Designation in Japan for Small-Cell Lung Cancer drugs.com ↗

Headlines link to the original publisher. Sources limited to a reviewed list of journals, regulators, and medical press.